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Abstract 
Epithelial sodium channels (ENaC) are localized at the apical membrane of the epithelium, and are 
responsible for salt and fluid reabsorption. Renal ENaC takes up salt, thereby controlling salt content in 
serum. Loss-of-function ENaC mutations lead to low blood pressure due to salt-wasting, while 
gain-of-function mutations cause impaired sodium excretion and subsequent hypertension as well as 
hypokalemia. ENaC activity is regulated by intracellular and extracellular signals, including hormones, 
neurotransmitters, protein kinases, and small compounds. Cyclic nucleotides are broadly involved in 
stimulating protein kinase A and protein kinase G signaling pathways, and, surprisingly, also appear to 
have a role in regulating ENaC. Increasing evidence suggests that the cGMP analog, CPT-cGMP, 
activates αβγ-ENaC activity reversibly through an extracellular pathway in a dose-dependent manner. 
Furthermore, the parachlorophenylthio moiety and ribose 2’-hydroxy group of CPT-cGMP are 
essential for facilitating the opening of ENaC channels by this compound. Serving as an extracellular 
ligand, CPT-cGMP eliminates sodium self-inhibition, which is a novel mechanism for stimulating salt 
reabsorption in parallel to the traditional NO/cGMP/PKG signal pathway. In conclusion, ENaC may be 
a druggable target for CPT-cGMP, leading to treatments for kidney malfunctions in salt reabsorption. 
Key words: amiloride-sensitive sodium channel; cyclic guanosine nucleotides; molecular docking; lung edema. 
Introduction 
Cyclic guanosine monophosphates (cGMP) are 
important cyclic nucleotides, playing a critical role in 
signal transduction in many different organisms1. 
Signal transduction in eukaryotic cells is essential for 
moderating the transmission of information through 
the cell membrane, and as a second messenger, cGMP 
regulates numerous essential processes in cells by 
amplifying external signals, for example, from hor-
mones and neurotransmitters. Cytosolic cGMP binds 
to cyclic nucleotide-gated ion channels1, 2 and phos-
phorylates protein kinase G (PKG) directly3-5.  
Amiloride-sensitive epithelial sodium channels 
(ENaC) behave as ligand-gated channels, similar to 
several other members of the ENaC/degenerin fami-
ly6. In the late part of the renal distal convoluted 
tubule, sodium is predominately reabsorbed via the 
electrogenic amiloride-sensitive ENaC. In the 
connecting tube, and the collecting duct, ENaC is the 
only pathway for retaining salt, and ENaC controls 
renal sodium excretion and provides the driving force 
for potassium secretion through the renal outer 
medullary potassium channel7. Loss-of-function 
ENaC genetic variants lead to low blood pressure, 
while gain-of-function mutants have been identified 
in Liddle’s syndrome, which is characterized by 
increased ENaC abundance, augmented opening 
time, and consequent salt retention, and eventually 
volume-expended hypertension8. An autosomal 
recessive form of pseudohypoaldosteronism type 1 is 
caused by mutations in ENaC, with usually severe 
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and persisting multiorgan symptoms 9.  
Five ENaC subunits have been cloned to date, 
namely α-, β-, γ-, δ-, and ε-ENaC. Among them, the β- 
and γ-subunits regulate the channel activity of the 
‘self-conducting’ α-, δ-, and ε-ENaC subunits when 
heterologously expressed in oocytes and cell lines 10-12. 
Luminal impermeable reagents and hormones have 
been confirmed to regulate ENaC in lung, kidney, and 
colon, and ENaC is regulated by a spectrum of protein 
kinases, such as PKG and protein kinase A (PKA) 13-15. 
However, our understanding of the cellular and 
molecular mechanisms by which cGMP regulates 
ENaC is incomplete.  
Regulation of Epithelial Sodium Chan-
nels by CPT-cGMP 
Cyclic GMP is one of the most prominent nucle-
otides in eukaryotic cells. Guanylyl cyclases elevate 
cell cGMP levels, which regulate complex signaling 
cascades through immediate downstream effectors, 
cGMP-dependent protein kinases, and cyclic nucleo-
tide-gated ion channels 1. CPT-cGMP is a derivative 
analog of parental cGMP, and has long been used for 
studying the NO/cGMP/PKG cascade 16, 17. 
Regulation of epithelial sodium channels by 
CPT-cGMP and its cAMP analog is summarized in 
Table 1. Species- and culture-dependence of ENaC 
properties, and the strategies used for elevating cell 
cGMP content, including nitric oxide (NO) donors 
and PKG isoform-specific cGMP analogs, may 
contribute to these divergent observations. 
Cyclic GMP/PKGII pathway 
To date, three PKG isoforms have been isolated, 
namely, PKGI-α, PKGI-β, and PKGII 18. Accumulating 
evidence from genetically engineered animals 
suggests that cardiovascular phenotypes are 
predominant with the PKGI knockout, while PKGII 
deficiency leads to dysfunction in epithelial tissues 
[19, 20]. Our results using Ussing chamber and 
voltage clamp techniques showed that 8-pCPT-cGMP 
increased the amiloride-sensitive short-circuit current 
across H441 cell monolayers and also increased 
heterologously expressed αβγδ-ENaC activity in a 
dose-dependent manner, most probably through the 
stimulation of PKGII enzymatic activity and 
subsequent activation of channel function 15 (Figure 
1). A carton briefly showed the interaction of cGMP 
and ENaC (Figure 2). Recent studies showed that 
PKG-interacting proteins mediate cellular targeting of 
PKG isoforms by interacting with their leucine zipper 
domains, and that protein recognition is mediated 
through surface charge interactions 19. 
Extracellular ligand pathway 
In sharp contrast to the native ENaC, 
heterologously expressed αβγ-ENaC in oocytes has 
been considered to be cAMP/PKA-independent, 
particularly for acute regulation. The cell-permeable 
PKGII isoform-specific activator, 8-pCPT-cGMP, 
acutely stimulates human, rat, and mouse αβγ-ENaC 
reversibly. Furthermore, intraoocyte domains of 
ENaC subunits and traditional soluble protein kinases 
may not be targets of this compound 20. A critical 
extracellular domain has recently been identified as 
the 8-CPT-cAMP binding site 21, indicating that 
8-CPT-cAMP is an extracellular ligand for ENaC 6, 21. 
Moreover, 8-CPT-cAMP can stimulate δβγ-ENaC up 
to approximately 3-fold, and αβγ-ENaC by 2-fold 14. 
Co-expression of δ-ENaC with αβγ channels 
conferred CPT-cAMP-mediated activation with an 
EC50 (concentration for 50% of maximal effect) value 
of 30 μM, similar to that for αβγ channels (49 μM) 22.  
 
Table 1. Regulation of sodium channel activity by nucleotides.  
Nucleotides Concentration Models Effects Ref. 
CPT-cGMP* 1 μM Xenopus 2F3 cells Increase in Isc 62 
 400 μM Rat ATII cells No change in Isc 63 
 2 mM Rat bronchioalveolar epithelial cells Increase in Isc/ 22Na influx 64, 65 
 100 μM Rat ATII cells Increase in whole cell activity 66 
 4 mM Human A549 cells Increase in whole cell activity 67 
 10 μM Frog urinary bladder epithelium Increase in single channel activity 68, 69 
 0.1 - 1000 μM Heterologous human αβγ ENaC in oocytes Increase in whole cell activity 16 
 0.5 mM Human lung lobes Increase in alveolar fluid clearance 24 
 0.2 mM  Mouse pleural tissues Increase in Isc 15 
 1 mM Rat ATII cells Decrease in single channel activity 56 
 100 μM Human A549 cells Decrease in whole cell activity 70 
CPT-cAMP 100 μM MDCK cells Increase in Isc  
 40 μM Liddle's disease lymphocytes Increase in whole cell activity 71 
 200 μM Heterologous human αβγ ENaC in oocytes Increase in whole cell activity 14, 21, 72 
 100 µM  BeWo cells Increase in whole cell activity 73 
*Abbreviations: ATII, alveolar type II epithelial; MDCK, Madin-Darby canine kidney; Isc, short-circuit current; CPT-cAMP, 8-pCPT-cAMP-Na; CPT-cGMP, 
8-pCPT-cGMP-Na. 
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Figure 1. Stimulation of heterologously expressed human ENaCs in Xenopus 
oocytes by cGMP. A: Representative current trace recorded at +40 mV and 
−100 mV. Oocytes were perfused with 8-pCPT-cGMP ranging from 1 μM to 1 
mM, as indicated by arrows. Amiloride was added to the bath before the 
recordings were terminated. B: Dose-response curve. The average 
cGMP-activated current fraction in the presence of cGMP (ΔI) was normalized 
to the maximal cGMP-elevated current (ΔImax) and plotted as a function of 
cGMP concentration. Dashed lines and the EC50 value were derived by fitting 
the raw data with the Hill equation. n=9. C: Average amiloride-sensitive (AS) 
αβγδ ENaC currents before (control) and after cGMP perfusion. Holding 
potential, −100 mV. n=10. Figure reprinted from 15, and used with permission. 
 
Figure 2. Extracellular and intracellular mechanisms for CPT-cGMP or 
CPT-cAMP to activate ENaC. These cell permeable compounds, when applied 
in vivo or in vitro, will stimulates ENaC activity by both acting as an external 
ligand to release self-inhibition and as a cytosolic signal molecule to phosphor-
ylate cGKII that subsequently activates ENaC.  
Relieving external sodium self-inhibition 
External sodium self-inhibition is an intrinsic 
feature of ENaC. A rapidly increase in extracellular 
sodium ions to a physiological concentration (150 mM 
for mammals and 100mM for amphibians) generates a 
maximal peak current in seconds, and then the per-
meability of ENaC to Na+ ions is gradually reduced to 
a relatively stable level with a current level of ap-
proximately half of the maximal value. This phe-
nomenon is called extracellular sodium self-inhibition 
of ENaC activity. It differs from the down-regulation 
of ENaC activity by slowly accumulating intracellular 
Na+ content in a feedback manner. External Na+ 
self-inhibition is a crucial mechanism to limit over-
whelming salt absorption to prevent a quick raise in 
epithelial cell volume and blood pressure. It main-
tains salt and fluid homeostasis at the luminal surface 
of the respiratory system to keep normal cilia beating 
in the airways, hyperpolarize apical membrane, and 
finely adjust fluid volume to host leukocytes and 
physiological regulators as the forefront battle against 
noxious aspirated insults 22. 
Our previous studies showed that external 
CPT-cAMP stimulated human, but not rat and 
murine, αβγ-ENaC in a dose-dependent and external 
sodium concentration-dependent fashion 14. ENaC 
mutations that abolished self-inhibition (βΔV348 and 
γH233R) almost completely eliminated CPT-cAMP 
mediated activation. In contrast, mutations that both 
enhanced self-inhibition and elevated CPT-cAMP 
sensitivity increased the stimulating effects of the 
compound. Our above data confirmed that 
CPT-cAMP acts as a ligand to regulate heterologous 
ENaC by relieving self-inhibition. Edelheit et al 23 
studied alanine mutations in 17 conserved charged 
residues of ENaC and found that these residues are 
involved in conformational changes that lead to 
channel constriction and to the sodium self-inhibition 
response upon sodium ion flooding. Similarly, our 
recent data showed that elimination of self-inhibition 
of αβγ-ENaC may be a novel mechanism for 
CPT-cGMP to stimulate salt reabsorption in the 
human epithelium (Figure 3) 24. 
Moiety specificity for CPT-cGMP serving 
as an ENaC ligand 
CPT-cGMP, an analog of CPT-cAMP, was 
capable of activating ENaC in the identical manner in 
cell-free outside-out patches 16. Both point mutations 
of the putative consensus PKG phosphorylation sites 
and truncation of entire cytosolic NH2- and 
COOH-terminal tails of ENaC did not alter the 
response to CPT-cGMP. The ENaC activity was 
activated to the same extent by CPT-cGMP in cells in 
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which PKGII expression was knocked down using 
small interfering RNA. As we demonstrated, the 
parachlorophenylthio moiety and ribose 2’-hydroxy 
group of CPT-cGMP are crucial for activating ENaC 
16, and CPT-cGMP may serve as a novel ENaC ligand 
in addition to activating the PKG signal. The strict 
requirement for both parachlorophenylthio and the 
ribose 2’-hydroxy groups helps to clarify the basis for 
the inconsistent results observed with the regulation 
of ENaC by a variety of cGMP analogs (Figure 4).  
 
 
Figure 3. CPT-cGMP modifies self-inhibition of αβγ ENaC in oocytes. Self-inhibition was initiated by fast switching the low sodium bath solution (1 mM sodium) to 
regular ND96 medium (96 mM sodium). A: Whole-cell current trace digitized at -60 mV. CPT-cGMP (0.2 mM) was added after the first three sweeps and washed out 
for the last three sweeps. B: Normalized and averaged currents; *P < 0.05 and **P < 0.01 versus the first sweep. C: Comparison of CPT-cGMP on self-inhibition of 
αβγ and δβγ ENaC channels. Paired traces were recorded before and after application of CPT-cGMP, n=9. Figure reprinted from 24, and used with permission. 
 
 
 
Figure 4. Domain-dependence of CPT-cGMP and CPT-cAMP analogs. A: 
Modified positions are shown for 8-pCPT-cGMP and 8-CPT-cAMP. B: The 
responses of human αβγ-ENaC to these compounds (0.2 mM) were compared: 
8-pCPTcGMP, (CPT-cGMP); 8-CPT-cAMP, (CPT-cAMP); 2-aminophenylthio- 
cGMP, (APT-cGMP); 8-pCPT-methylated ribose 2’-hydroxy (2’-O-Me)-cGMP 
(CPT-2’OMe-cGMP); Sp-8-Br-cGMP, (Br-cGMP); 8-CPT-2’-O-Me-cAMP, 
(CPT-2’OMe-cAMP), 4-chlorothiolphenol, (CPT); a mixture of CPT and KOH, 
(CPT+OH). The normalized currents before and after application of these 
compounds were compared with that of the standard cGMP molecule (Std 
cGMP). **P < 0.01, *P < 0.05. Numbers in parentheses are the number of 
oocytes examined for each group. Figure reprinted from 16, and used with 
permission. 
 
CPT-cGMP ligand docking to ENaC 
In our previous experiment, we constructed 
mutants abolishing (βV348 and γH233R), or 
augmenting (αY458A and γM432G), ENaC 
self-inhibition 14, 24. The mutations eliminating 
self-inhibition resulted in a loss of response to 
CPT-cGMP, whereas those enhancing self-inhibition 
facilitated the stimulatory effects of this compound. 
Figure 5 shows the potential binding sites for the 
CPT-cGMP ligand in ENaC domains that are crucial 
for self-inhibition. βV348 is located in the center of the 
palm region of the subunit, and γH233 is located in the 
vicinity of the putative binding site for protons. These 
domains potentially directly or allosterically interact 
with CPT-cGMP.  
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Self-Inhibition as a Therapeutic Mecha-
nism 
Reagents able to release self-inhibition 
Previous results suggested that external Zn2+ 
rapidly and reversibly activates ENaC in a 
dose-dependent manner by relieving the channel 
from sodium self-inhibition25. In addition to Zn, ex-
tracellular chloride 26, temperature27, 28, halogenated 
gases 27-29, sulfhydryl group-modifying reagents (e.g., 
p-chloromercuriphenylsulfonate, pCMPS and 
p-chloromercuribenzoate, pCMB) 30, p-chloromer-
curibenzoate benzimidazolylguanidine 30-33, protons 
26, cupper 34, and proteases 28, 35, 36 are also proposed to 
modulate ENaC-gating by relieving sodium 
self-inhibition. A classic earlier review summarized 
most of these reagents27,37,38. Non-cleaved channels 
have a low intrinsic open probability that may reflect 
enhanced channel inhibition by external sodium, and 
cleavage at a minimum of two sites within the α- or 
γ-ENaC subunits is required to activate the channel, 
presumably by releasing inhibitory fragments 39. The 
extent of ENaC proteolysis is dependent on channel 
residency time at the plasma membrane, as well as on 
the balance between levels of expression of proteases 
that activate epithelial sodium channels and inhibitors 
of these proteases. For example, furin cleavage of 
ENaC subunits activates the channels by relieving 
sodium self-inhibition, and this activation requires 
that the α-ENaC subunit be cleaved twice35. 
Specific domains/sites 
changing self-inhibition 
His(88) and Asp(516) of the 
γ subunit play a role in the 
Zn2+-regulating sodium 
self-inhibition mentioned above. 
Recent studies showed that 
palmitoylation of the γ subunit 
activates ENaC by increasing 
the open probability of the 
channels 40. ENaC mutants with 
the mutations γC33A, γC41A, or 
γC33A/C41A have significantly 
enhanced sodium self-inhibition 
and reduced open probability 
compared with wild type 
ENaCs, suggesting that ENaC 
palmitoylation is an important 
post-translational mechanism of 
channel regulation. Exon 11 
within the human α, β, and γ 
ENaC genes encodes 
structurally homologous yet 
functionally diverse domains, 
and exon 11 in the α-subunit encodes a module that 
regulates channel gating 41. 
In contrast to the other mutations, γL511Q 
largely eliminated the sodium self-inhibition re-
sponse, reflecting a down-regulation of ENaC open 
probability by extracellular sodium 42. γL511Q is a 
gain-of-function human ENaC variant and it enhances 
ENaC activity by increasing channel open probability 
and dampens channel regulation by extracellular so-
dium and proteases 42. 
Therapeutic effects of targeting self-inhibition  
Renal handling of sodium and water is abnormal 
in chronic kidney diseases. Filtrated sodium is 
reabsorbed from the glomerular filtrate, and 
potassium is secreted through a tight epithelium in 
the kidney. Sodium crosses the apical membrane and 
enters the epithelial cell through the ion-selective 
ENaC 43. ENaC is responsible for the reabsorption of 
sodium through the apical membrane of the 
connecting tubule and the collecting duct, and plays a 
key role in controlling sodium balance, extracellular 
fluid volume, and blood pressure 44. Regulated 
epithelial sodium channel proteolysis has been 
observed in rat kidney and in human airway epithelia. 
Pseudohypoaldosteronism type 1 is a monogenic 
disorder of mineralocorticoid resistance characterized 
by salt-wasting, hyperkalemia, high aldosterone lev-
els, and failure to thrive 45. An autosomal recessive 
form of pseudohypoaldosteronism type 1 is caused by 
mutations in ENaC, and is usually associated with 
 
Figure 5. Homology model of trimeric human αβγ ENaC. The subunits are color-coded as follows: α, grey 
(back, center); β, cyan (front, right); γ, red (front, left). A: Side view of the entire trimer. Two dashed grey lines 
indicate the plasma membrane. The locations of the mutations γH233 and βV348 are marked by yellow boxes. B: 
Close-up view, showing the location of βV348. Note that βV348 is located in the center of the palm region of the 
subunit, and its downstream residues extend to the wrist region of the subunit that seems to be important in the 
coupling between extracellular domains to the pore region. Thus, deletion of βV348 may change the position and 
orientation of the downstream residues. γH233 is located in the vicinity of the putative binding site for protons. 
Since 8-CPT-cGMP is much larger than a proton, its binding site may include the H233 residue. 
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severe and persisting multiorgan symptoms. The 
relief of self-inhibition by CPT-cAMP contributes to 
the acute effects, in addition to the well-known 
cAMP-PKA signal pathway 14. In fact, the clinical 
relevance of the abnormal regulation of ENaC by 
CPT-cAMP has been implicated in the upregulation of 
ENaC in autosomal recessive 
pseudohypoaldosteronism type 1 46. 
Another distressed transapical sodium transport 
occurs in injured lungs, for example, acute lung injury 
(ALI) and acute respiratory distress syndrome 
(ARDS) (please see classical reviewes 47-51). Apical 
ENaC contributes to up to 60% of transepithelial 
sodium transport in mammalian lungs under 
physiological conditions. This critical process is 
sensitive to aspirated pollutants, allergens, pathogens, 
and bacterial endotoxins. In addition to increased 
leaking through alveolar microvascular endothelium 
(indirect ALI), lung edema ususally results from 
reduced edema fluid resolution via ENaC (direct 
ALI). ENaC is a promising target for developing new 
therapeutical strategies to alleviate lung edema, at 
least for the phenotype of direct ALI 52, 53.  
CPT-cGMP and self-inhibition 
Human serum cGMP level is 6 nM and 3-time 
greater in human bronchoalveolar lavage 54. It appears 
that cGMP may serve as an autocrine and paracrine to 
regulate ENaC function. However, the effective dose 
for CPT-cGMP and CPT-cAMP to blunt self-inhibition 
is micromolar, suggesting an uncertain physiological 
role for cGMP and analogs. A large dose of cGMP 
compound (1 mg/kg) was administered to patients as 
reported by two clinical trials 55, and numerous pre-
clinical studies (from 100 µM to 2 mM) 56-58. It is 
therefore feasible to apply aerosolized nucleotides to 
mitigate edematous lung injury. We have demon-
strated that CPT-cGMP up-regulates ENaC via two 
mechanisms: release self-inhibition externally and 
activates ENaC through cGMP/cGKII pathway in-
tracellularly 24. Thus, these compounds could regulate 
sodium absorption via either or both mechanisms in a 
cell permeability-dependent manner. Administration 
of cAMP could be a potent pharmaceutical treatment 
for edematous lung injury 59, and cGMP may have 
similar potential. cGMP increased in murine and rat 
lungs both in vivo and in vitro following NO 
application 60, and increased cGMP may augment the 
cGMP-sensitive pathway for lung fluid removal from 
alveolar sacs 61. Our previous study demonstrated for 
the first time that PKGII is an ENaC activator in 
non-ciliated bronchial secretory cells 15. Accordingly, 
upregulation of the rate-limiting ENaCs in respiratory 
epithelial cells by specific PKGII activators may be a 
potent clinicopharmaceutical strategy for alleviating 
airspace flooding in fatal edematous lung diseases. 
The observation of our previous study that specific 
moieties of 8-pCPT-cGMP are required for activating 
ENaC may provide pivotal information for 
developing potential ENaC channel openers 
structurally related to 8-pCPT-cGMP, which would be 
extremely useful for treating diseases associated with 
lower ENaC function. We postulate that when the 
tight epithelial layer is damaged, for example, in in-
jured lungs, even though the mixture of extracellular 
matrix proteins, including collagens, albumin, and 
fibrins, will seal the epithelial cell-free alveolar sur-
face, the potency of ENaC stimulator will be limited 
significantly. Therefore, the integrity of the tight al-
veolar epithelium should be a key factor to be con-
sidered for the usage of ENaC agonists. The antici-
pated restore of alveolar fluid clearance may be seen 
at the earlier stage of ALI and lung edema mainly 
caused by injured pulmonary vasculature or post re-
generation of alveolar epithelium by stem 
cells/progenitors. 
Conclusions and Perspectives 
ENaC is involved in edema formation and kid-
ney disorders. cGMP, either by serving as a ligand to 
regulate cyclic nucleotide-gated ion channels or by 
acting upstream of the PKG signaling systems, has a 
role in the elimination of ENaC self-inhibition, 
suggesting a novel mechanism for CPT-cGMP to 
stimulate salt reabsorption. Compounds such as 
specific PKGII activators and/or self-inhibition 
inhibitors could be the basis for novel pharmaceutical 
interventions for combating diseases associated with 
impaired ENaC function. Future directions for study 
include optimizing cGMP structure to potentiate its 
efficacy in activating ENaC, evaluating its pharma-
ceutical relevance in preclinical and clinical models 
with impaired ENaC activity, and confirming the 
binding sites of cGMP in ENaC.  
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